2020 American Transplant Congress
Safety of Belatacept in HIV-Positive Kidney Transplant Recipients
*Purpose: Kidney allograft survival in HIV-infected patients is lower than in the general population. Belatacept (instead of anticalcineurins (CNI)) has been shown to have a…2020 American Transplant Congress
Declining Inpatient Mortality for Patients with Human Immunodeficiency Virus (HIV) and Cirrhosis: A Temporal Analysis of the Nationwide Inpatient Sample
Weill Cornell Medicine, New York, NY
*Purpose: Despite the advent of highly effective anti-retroviral therapy, HIV remains a major health burden. Though life expectancy has improved, patients are now dying from…2020 American Transplant Congress
An OPO’s Experience in Increasing Transplantation with the Hope Project
*Purpose: The purpose of this report is to describe one OPO’s experience in participating in the Hope Project. This research project is designed to evaluate…2020 American Transplant Congress
Barriers for Kidney Transplant Evaluation among People Living with HIV and End-Stage Renal Disease in Mississippi
*Purpose: The number of Kidney transplants (KTx) among people living with HIV (PLWH) who develop end-stage renal disease (ESRD) has been increasing in many transplant…2020 American Transplant Congress
The Forgiven Disease: Outcomes of Lung Transplantation in Two HIV-Infected Patients
*Purpose: Human immunodeficiency virus (HIV) seropositivity is generally considered a contraindication to lung transplantation (LTx). HIV-infected adults are at higher risk of developing chronic lung…2020 American Transplant Congress
Conversion to Belatacept in HIV(+) Renal Transplant Recipients
Mount Sinai Hospital, New York, NY
*Purpose: HIV(+) renal transplant recipients were excluded from phase III trials of belatacept, and currently there are only scattered case reports.*Methods: This was a single…2019 American Transplant Congress
Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease
*Purpose: Patients with HIV and end-stage renal disease (ESRD) experience higher mortality on dialysis than those without HIV. These HIV+ dialysis patients may face barriers…2019 American Transplant Congress
Opening the Doors of Hope: HIV-Positive Living Kidney Donation
Duke University Medical Center, Durham, NC
*Purpose: Living donation (LD) has been allowed under the HOPE Act since 2013, yet to date there have been no HIV+ LD organ transplants performed…2019 American Transplant Congress
Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-Infected End-Stage Renal Disease Patients: Pre vs. Post-Transplant
*Purpose: End-stage renal disease (ESRD) patients co-infected with HCV and HIV have access to effective treatment options for HCV infection. However, they also have access…2019 American Transplant Congress
HIV Resistance among HOPE Donor Referrals
*Purpose: After success in South Africa, HIV+ deceased donor (HIV D+) organs can now be used for transplant to HIV+ recipients in the US under…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »